 |
|
About Oxitec Overview |
Overview Oxitec has developed and patented a novel technology platform which promises a step change in the cost-effectiveness and breadth of application of the Sterile Insect Technique. This platform is called RIDL® and is the basis for providing effective and environment friendly pest control to agriculture and public health. Oxitec has generated product candidates for four insect pest control markets, and has advanced its lead candidate to the final testing phase of the development pathway in the USA. Oxitec Limited was founded in 2002 to develop and commercialize leading edge science and technology invented at the University of Oxford. Oxitec is located near Oxford in the United Kingdom and employs an energetic, professional team of 25 people. Our approach to insect control was recognised by the Bill and Melinda Gates Foundation Grand Challenges for Global Health Initiative with an award as part of a $20 million consortium developing genetic strategies to control disease-carrying mosquitoes. |
Investors The University of Oxford |
